CYP2C19 genetic testing for Mavacamten and ischaemic stroke treatment: What does the result mean for cardiovascular prescribers in the UK and Europe?
Emma F MagavernJohn H McDermottMark J CaulfieldWilliam G NewmanPublished in: European heart journal. Cardiovascular pharmacotherapy (2024)
Keyphrases